Aberrant epigenetic silencing is triggered by a transient reduction in gene expression

PLoS ONE

Volumn 4, Issue 3, 2009, Pages

  Oyer, Jon A ^a   Chu, Adrian ^a   Brar, Sukhmani ^a   Turker, Mitchell S ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOXYCYCLINE; HISTONE; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; LYSINE; PRIMER DNA;

ACETYLATION; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DEACETYLATION; DNA METHYLATION; EPIGENETICS; GENE ACTIVATION; GENE EXPRESSION; GENE SILENCING; MOLECULAR MECHANICS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROMOTER REGION; ALLELE; ANIMAL; CULTURE MEDIUM; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETICS;

MAMMALIA;

ACETYLATION; ALLELES; ANIMALS; CULTURE MEDIA; DNA PRIMERS; DOXYCYCLINE; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION; GENE SILENCING; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; MICE; PROMOTER REGIONS, GENETIC;

EID: 62849100430     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0004832     Document Type: Article

References (43)

1. Sawan C, Vaissieère T, Murr R, Herceg Z (2008) Epigenetic drivers and genetic passengers on the road to cancer. Mutat Res 642: 1-13. doi:10.1016/j.mrfmmm.2008.03.002.
2. Esteller M (2008) Epigenetics in cancer. N Engl J Med 358: 1148-59. doi:10.1056/NEJMra072067.
3. Turker MS (2002) Gene silencing in mammalian cells and the spread of DNA methylation. Oncogene 21: 5388-93. doi:12154401.
4. Yates PA, Burman R, Simpson J, Ponomoreva ON, Thayer MJ, et al. (2003) Silencing of mouse Aprt is a gradual process in differentiated cells. Mol Cell Biol 23: 4461-70.
5. Mund C, Brueckner B, Lyko F (2006) Reactivation of epigenetically silenced genes by DNA methyltransferase inhibitors: basic concepts and clinical applications. Epigenetics : official journal of the DNA Methylation Society 1: 7-13.
6. Gronbaek K, Hother C, Jones PA (2007) Epigenetic changes in cancer. APMIS 115: 1039-59. doi:10.1111/j.1600-0463.2007.apm_636.xml.x.
7. Reik W (2007) Stability and flexibility of epigenetic gene regulation in mammalian development. Nature 447: 425-32. doi:10.1038/nature05918.
8. Erwin JA, Lee JT (2008) New twists in X-chromosome inactivation. Curr Opin Cell Biol 20: 349-55. doi:10.1016/j.ceb.2008.04.007.
9. Siegfried Z, Eden S, Mendelsohn M, Feng X, Tsuberi BZ, et al. (1999) DNA methylation represses transcription in vivo. Nat Genet 22: 203-6. doi:10.1038/ 9727.
10. Mutskov V, Felsenfeld G (2004) Silencing of transgene transcription precedes methylation of promoter DNA and histone H3 lysine 9. EMBO J 23: 138-49. doi:10.1038/sj.emboj.7600013.
11. Strunnikova M, Schagdarsurengin U, Kehlen A, Garbe JC, Stampfer MR, et al. (2005) Chromatin inactivation precedes de novo DNA methylation during the progressive epigenetic silencing of the RASSF1A promoter. Mol Cell Biol 25: 3923-33. doi:10.1128/MCB.25.10.3923-3933.2005.
12. Banelli B, Casciano I, Romani M (2000) Methylation-independent silencing of the p73 gene in neuroblastoma. Oncogene 19: 4553-6. doi:10.1038/ sj.onc.1203807.
13. Markus J, Garin MT, Bies J, Galili N, Raza A, et al. (2007) Methylation-independent silencing of the tumor suppressor INK4b (p15) by CBFbeta-SMMHC in acute myelogenous leukemia with inv(16). Cancer Res 67: 992-1000. doi:10.1158/0008-5472.CAN-06-2964.
14. Kondo Y, Shen L, Cheng AS, Ahmed S, Boumber Y, et al. (2008) Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation. Nat Genet 40: 741-50. doi:10.1038/ng.159.
15. Caslini C, Capo-chichi CD, Roland IH, Nicolas E, Yeung AT, et al. (2006) Histone modifications silence the GATA transcription factor genes in ovarian cancer. Oncogene 25: 5446-61. doi:10.1038/sj.onc.1209533.
16. Leu Y, Yan PS, Fan M, Jin VX, Liu JC, et al. (2004) Loss of estrogen receptor signaling triggers epigenetic silencing of downstream targets in breast cancer. Cancer Res 64: 8184-92. doi:10.1158/ 0008-5472.CAN-04-2045.
17. Raval A, Tanner SM, Byrd JC, Angerman EB, Perko JD, et al. (2007) Downregulation of death-associated protein kinase 1 (DAPK1) in chronic lymphocytic leukemia. Cell 129: 879-90. doi:10.1016/j.cell.2007.03.043.
18. Krishnamachary B, Zagzag D, Nagasawa H, Rainey K, Okuyama H, et al. (2006) Hypoxia-inducible factor-1-dependent repression of E-cadherin in von Hippel-Lindau tumor suppressor-null renal cell carcinoma mediated by TCF3, ZFHX1A, and ZFHX1B. Cancer Res 66: 2725-31. doi:10.1158/ 0008-5472.CAN-05-3719.
19. Bindra RS, Gibson SL, Meng A, Westermark U, Jasin M, et al. (2005) Hypoxia-induced down-regulation of BRCA1 expression by E2Fs. Cancer Res 65: 11597-604. doi:10.1158/0008-5472.CAN-05-2119.
20. Bindra RS, Crosby ME, Glazer PM (2007) Regulation of DNA repair in hypoxic cancer cells. Cancer Metastasis Rev 26: 249-60. doi:10.1007/ s10555-007-9061-3.
21. Lee S, Kim J, Kim W, Lee Y (2008) Hypoxic silencing of tumor suppressor RUNX3 by histone modification in gastric cancer cells. Oncogene; Available: http://www.nature.com/onc/journal/vaop/ncurrent/abs/ onc2008377a.html.
22. Li QL, Ito K, Sakakura C, Fukamachi H, Inoue KI, et al. (2002) Causal relationship between the loss of RUNX3 expression and gastric cancer. Cell 109: 113-24. doi:11955451.
23. Li Q, Kim H, Kim W, Choi J, Lee YH, et al. (2004) Transcriptional silencing of the RUNX3 gene by CpG hypermethylation is associated with lung cancer. Biochem Biophys Res Commun 314: 223-8. doi:14715269.
24. Gossen M, Bujard H (1992) Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci U S A 89: 5547-51. doi:PMC49329.
25. Turker MS, Mummaneni P, Bishop PL (1991) Region- and cell type-specific de novo DNA methylation in cultured mammalian cells. Somat Cell Mol Genet 17: 151-7. doi:2011793.
26. Dodge JE, Kang Y, Beppu H, Lei H, Li E (2004) Histone H3-K9 methyltransferase ESET is essential for early development. Mol Cell Biol 24: 2478-86.
27. Tachibana M, Ueda J, Fukuda M, Takeda N, Ohta T, et al. (2005) Histone methyltransferases G9a and GLP form heteromeric complexes and are both crucial for methylation of euchromatin at H3-K9. Genes Dev 19: 815-26. doi:10.1101/gad.1284005.
28. Yan C, Boyd DD (2006) Histone H3 acetylation and H3 K4 methylation define distinct chromatin regions permissive for transgene expression. Mol Cell Biol 26: 6357-71. doi:PMC1592829.
29. McGarvey KM, Fahrner JA, Greene E, Martens J, Jenuwein T, et al. (2006) Silenced tumor suppressor genes reactivated by DNA demethylation do not return to a fully euchromatic chromatin state. Cancer Res 66: 3541-9. doi:10.1158/0008-5472.CAN-05-2481.
30. Egger G, Aparicio A, Escobar S, Jones P (2007) Inhibition of Histone Deacetylation Does Not Block Resilencing of p16 after 5-Aza-29-Deoxycytidine \ldots. Cancer Res; Available: http://cancerres.aacrjournals.org/cgi/content/abstract/67/1/346.
31. Shin-Darlak CY, Skinner AM, Turker MS (2005) A role for Pms2 in the prevention of tandem CC→TT substitutions induced by ultraviolet radiation and oxidative stress. DNA Repair (Amst) 4: 51-7. Available: http://www.ncbi.nlm.nih.gov/pubmed/15533837. Accessed 11 Feb 2009.
32. Hall DB, Struhl K (2002) The VP16 activation domain interacts with multiple transcriptional components as determined by protein-protein cross-linking in vivo. J Biol Chem 277: 46043-50. doi:10.1074/ jbc.M208911200.
33. Stirzaker C, Song JZ, Davidson B, Clark SJ (2004) Transcriptional gene silencing promotes DNA hypermethylation through a sequential change in chromatin modifications in cancer cells. Cancer Res 64: 3871-7. doi:10.1158/ 0008-5472.CAN-03-3690.
34. Chen H, Yan Y, Davidson TL, Shinkai Y, Costa M (2006) Hypoxic stress induces dimethylated histone H3 lysine 9 through histone methyltransferase G9a in mammalian cells. Cancer Res 66: 9009-16. doi:66/ 18/9009.
35. Chen H, Ke Q, Kluz T, Yan Y, Costa M (2006) Nickel ions increase histone H3 lysine 9 dimethylation and induce transgene silencing. Mol Cell Biol 26: 3728-37. doi:10.1128/MCB.26.10.3728-3737.2006.
36. Lee YW, Klein CB, Kargacin B, Salnikow K, Kitahara J, et al. (1995) Carcinogenic nickel silences gene expression by chromatin condensation and DNA methylation: a new model for epigenetic carcinogens. Mol Cell Biol 15: 2547-57.
37. Bachman KE, Park BH, Rhee I, Rajagopalan H, Herman JG, et al. (2003) Histone modifications and silencing prior to DNA methylation of a tumor suppressor gene. Cancer Cell 3: 89-95.
38. Fahrner JA, Eguchi S, Herman JG, Baylin SB (2002) Dependence of histone modifications and gene expression on DNA hypermethylation in cancer. Cancer Res 62: 7213-8.
39. Cameron EE, Bachman KE, Myöhänen S, Herman JG, Baylin SB (1999) Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer. Nat Genet 21: 103-7. doi:10.1038/5047.
40. Li F, Papworth M, Minczuk M, Rohde C, Zhang Y, et al. (2007) Chimeric DNA methyltransferases target DNA methylation to specific DNA sequences and repress expression of target genes. Nucleic Acids Res 35: 100-12. doi:10.1093/ nar/gkl1035.
41. Schübeler D, Lorincz MC, Cimbora DM, Telling A, Feng YQ, et al. (2000) Genomic targeting of methylated DNA: influence of methylation on transcription, replication, chromatin structure, and histone acetylation. Mol Cell Biol 20: 9103-12.
42. Hoffman AR, Hu JF (2006) Directing DNA methylation to inhibit gene expression. Cell Mol Neurobiol 26: 425-38. doi:10.1007/s10571-006-9057-5.
43. Yates PA, Burman RW, Mummaneni P, Krussel S, Turker MS (1999) Tandem B1 Elements Located in a Mouse Methylation Center Provide a Target for de Novo DNA Methylation. J Biol Chem 274: 36357-36361. doi:10.1074/ jbc.274.51.36357.